Advertisement

Journal of Gastrointestinal Surgery

, Volume 17, Issue 6, pp 1032–1035 | Cite as

Adenocarcinoma of the Esophagus in the Young

  • Arzu Oezcelik
  • Shahin Ayazi
  • Steven R. DeMeester
  • Joerg Zehetner
  • Emmanuele Abate
  • Joie Dunn
  • Kimberly S. Grant
  • John C. Lipham
  • Jeffrey A. Hagen
  • Tom R. DeMeester
SSAT Quick Shot Presentation

Abstract

Introduction

Practitioners have noted a striking increase in the number of young patients under the age of 40 years old who develop esophageal adenocarcinoma. The aim of this study was to characterize the presentation, pathology and therapeutic outcome of these young patients.

Methods

The records of patients who presented to the Foregut Surgical Service at the University of Southern California with esophageal adenocarcinoma between 2000 and 2007 were retrospectively reviewed. The presentation, tumor stage and histology, therapy and outcome of the patients under the age of 40 were compared to those ≥40.

Results

Of the 374 patients reviewed, 20 (5 %) were under the age of 40. There were two patients in their second and 18 in their third decade of life. The youngest patient was 25 years old. A history of gastroesophageal reflux disease or Barrett’s esophagus was less common in patients <40 than in those ≥40; 15 and 5 % compared to 61 and 46 %. Similarly, patients <40 had a significantly longer time interval between the onset of symptoms and the diagnosis of their cancer than those ≥40; 4.5 vs. 2 months, p = 0.04. They also had a higher prevalence of stage IV disease (30 vs. 6 %, p = 0.0003), a shorter time to recurrence (9.5 vs.19 month, p = 0.002), and a poorer median survival (17 vs. 43 month, p = 0.04).

Conclusion

Esophageal adenocarcinoma in patients <40 years old commonly presents with an advanced stage of the disease and an associated poor survival. This is likely due to a low index of suspicion that dysphagia seen in younger patients is due to a malignancy.

Keywords

Esophageal cancer Neoadjuvant therapy Long-term outcome Esophagectomy Survival Age 

References

  1. 1.
    Blot, W. J., Devesa, S. S., Kneller, R. W., and Fraumeni, J. F., Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287–1289.PubMedCrossRefGoogle Scholar
  2. 2.
    Pohl, H. and Welch, H. G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst2005; 97: 142–146.PubMedCrossRefGoogle Scholar
  3. 3.
    Patil, P. K., Patel, S. G., Mistry, R. C., Deshpande, R. K., and Desai, P. B. Cancer of the esophagus in young adults. J Surg Oncol 1992; 50: 179–182.PubMedCrossRefGoogle Scholar
  4. 4.
    Vallbohmer, D., Holscher, A. H., Brabender, J., Prenzel, K., Gutschow, C., Schroder, W., Metzger, R., and Bollschweiler, E. Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a difference? Dis Esophagus 2008; 21: 596–600.PubMedCrossRefGoogle Scholar
  5. 5.
    Mori, M., Ohno, S., Tsutsui, S., Matsuura, H., Kuwano, H., and Sugimachi, K. Esophageal carcinoma in young patients. Ann Thorac Surg 1990; 49: 284–286.PubMedCrossRefGoogle Scholar
  6. 6.
    Adam, D. J., Craig, S. R., Sang, C. T., Walker, W. S., and Cameron, E. W. Oesophagogastrectomy for carcinoma in patients under 50 years of age. J R Coll Surg Edinb 1996; 41: 371–373.PubMedGoogle Scholar
  7. 7.
    Abate, E., DeMeester, S.R., Zehetner, J., Oezcelik, A., Ayazi, S., Costales J., Banki, F., Lipham J.C., Hagen J.A., DeMeester T.R. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg. 2010 ; 210(4):428–35.PubMedCrossRefGoogle Scholar
  8. 8.
    Enzinger, P. C. and Mayer, R. J. Esophageal cancer. N Engl J Med 2003; 349: 2241–2252.PubMedCrossRefGoogle Scholar
  9. 9.
    Lambert R, Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Baillieres Best Pract Res Clin Gastroenterol. 2007;21:921–945.CrossRefGoogle Scholar
  10. 10.
    Foster, M. A. and Attwood, S. E. Current guidelines fail young patients with oesophagogastric cancer. Gut 2002; 51: 296–297.PubMedCrossRefGoogle Scholar
  11. 11.
    Hashemi, N., Loren, D., DiMarino, A. J., and Cohen, S. Presentation and prognosis of esophageal adenocarcinoma in patients below age 50. Dig Dis Sci 2009; 54: 1708–1712.PubMedCrossRefGoogle Scholar
  12. 12.
    Hamouda, A., Forshaw, M., Rohatgi, A., Mirnezami, R., Botha, A., and Mason, R. Presentation and survival of operable esophageal cancer in patients 55 years of age and below. World J Surg 2010; 34: 744–749.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2013

Authors and Affiliations

  • Arzu Oezcelik
    • 1
  • Shahin Ayazi
    • 1
  • Steven R. DeMeester
    • 1
  • Joerg Zehetner
    • 1
  • Emmanuele Abate
    • 1
  • Joie Dunn
    • 1
  • Kimberly S. Grant
    • 1
  • John C. Lipham
    • 1
  • Jeffrey A. Hagen
    • 1
  • Tom R. DeMeester
    • 1
    • 2
  1. 1.Division of Thoracic Foregut Surgery, Department of Surgery, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA
  2. 2.Department of Surgery, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations